How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an executive board of patient representatives, each elected by the Alliance member organisations and representing their region. Patient-led and patient-driven, we hold a unique position in the field of hepatitis as genuinely standing up for the 400 million people living with hepatitis worldwide. The new Alliance regional board was elected in November 2014 and met in London this month for the first time to attend the Annual Executive Board Meeting. 

True patient champions, our newly elected regional board members are extremely committed to the fight against viral hepatitis. From reviewing internal processes of the organisation to advising on the Alliance’s strategic objectives, the board members examined and debated the key elements of how the Alliance functions over a two day meeting in London, UK on 9th-10th February. The meeting was attended by the President and board member, Charles Gore, executive board members; Danjuma Adda (Africa), Su Wang (the Americas), George Kalamitsis (Europe), Dee Lee (Western Pacific) and was joined by observer Dr Gottfried Hirnschall, Director of the HIV/AIDS Department at WHO, as well as Helen Tyrell, Non-Executive Board Member and CEO of Hepatitis Australia, Alliance CEO Raquel Peck and COO Karine Belondrade. The advice and feedback we received from our board members, your representatives, is instrumental to our work and the productive meeting has triggered many further actions and even new directions for the Alliance to explore. We are looking forward to working with them over the coming year and encourage all our members to keep in regular contact with them. Through them, you have direct influence over what we do and how we work.